ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Incorporation size of lymph node metastasis focus and pre-ablation stimulated Tg could more effectively predict clinical outcomes in differentiated thyroid cancer patients without distant metastases

Xie, Jiahao; Chen, Pan; Wang, Jing; Luo, Xiaoqin; Luo, Jiaxin; Xiong, Xiaoli; Li, Chunyan; Pan, Liqin; Wu, Juqing; Feng, Huijuan; Ouyang, Wei*南方医科大学
Frontiers in Endocrinology2023-3-21DOI: 10.3389/fendo.2023.1094339
1被引11阅读
引用收藏
分享

摘要

BackgroundThe size of lymph node metastasis (LNM) and pre-ablation stimulated Tg (ps-Tg) were key predictors of clinical prognosis in differentiated thyroid cancer (DTC) patients, however, very few studies combine the above two as predictors of clinical prognosis of DTC patients. MethodsPersistent/recurrent disease and clinicopathologic factors were analyzed in 543 DTC patients without distant metastases who underwent LN dissection, near-total/total thyroidectomy, and radioiodine ablation. ResultsIn the multivariate analysis, size of LNM, ps-Tg, and the activity of I-131 significantly correlated with long-term remission. The optimal cutoff size of LNM 0.4 cm-1.4 cm (intermediate-risk patients) and >1.4cm (high-risk patients) increased the recurrence risk (hazard ratio [95% CI], 4.674 [2.881-7.583] and 13.653 [8.135-22.913], respectively). Integration of ps-Tg into the reclassification risk stratification showed that ps-Tg <= 10.0 ng/mL was relevant to a greatly heightened possibility of long-term remission (92.2%-95.4% in low-risk patients, 67.3%-87.0% in intermediate-risk patients, and 32.3%-57.7% in high-risk patients). ConclusionThe cutoff of 0.4 cm and 1.4 cm for a definition of size of LNM in DTC patients without distant metastases can reclassify risk assessment, and incorporating ps-Tg could more effectively predict clinical outcomes and modify the postoperative management plan.

学科与关键词

关键词
differentiated thyroid cancerlymph node metastasispre-ablation stimulated Tg131I therapyprognosis
相关
加载中…
  • Incorporation size of lymph node metastasis focus and pre-ablation stimulated Tg could more effectively predict clinical outcomes in differentiated thyroid cancer patients without distant metastases (vol 14, 1094339, 2023)
    Xie, Jiahao; Chen, Pan; Wang, Jing; Luo, Xiaoqin; Luo, Jiaxin; Xiong, Xiaoli; Li, Chunyan; Pan, Liqin; Wu, Juqing; Feng, Huijuan; Ouyang, Wei*Frontiers in Endocrinology, 2023, 14: 1221004.
  • Preoperative serum thyroglobulin is a risk factor of skip metastasis in papillary thyroid carcinoma
    Huang, Ziyang; Song, Muye; Wang, Shujie; Huang, Jianhao; Shi, Hongyan; Huang, Yijie; Yin, Ying; Liu, Yongchen*; Wu, Zeyu*Annals of Translational Medicine, 2020, 8(6): 389.被引 9
  • High Ki-67 LI is an Important Factor for Good Early Outcomes After Radioiodine Therapy in Patients with Intermediate to High-Risk Papillary Thyroid Cancer
    Luo, X.; Ouyang, W.Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Vienna, AUSTRIA, 2023-09-09 To 2023-09-13.
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Endocrinology
发表日期
2023-03-21
卷期
第 14 卷
页码
1094339
DOI
10.3389/fendo.2023.1094339
成果收录
SCIE

作者

  • X

    Xie, Jiahao (第一作者)

    southern med univ

  • C

    Chen, Pan

    southern med univ

查看全部 11 位作者收起作者
  • W

    Wang, Jing

    southern med univ

  • L

    Luo, Xiaoqin

    southern med univ

  • L

    Luo, Jiaxin

    southern med univ

  • X

    Xiong, Xiaoli

    southern med univ

  • L

    Li, Chunyan

    southern med univ

  • P

    Pan, Liqin

    southern med univ

  • W

    Wu, Juqing

    southern med univ

  • F

    Feng, Huijuan

    southern med univ

  • O

    Ouyang, Wei (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417